SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The S&P 500 is experiencing heightened volatility as market participants weigh geopolitical risks in the Middle East against a 48-hour ultimatum impacting global energy supplies and shipping lanes. Investors are actively debating whether these tensions signal a temporary pullback or a more significant structural decline, while closely monitoring treasury yields and institutional hedging behavior for direction.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending as market participants react to escalating geopolitical tensions in the Middle East, specifically surrounding threats to the Strait of Hormuz and potential impacts on critical energy infrastructure. The community is actively debating whether ongoing diplomatic rhetoric serves as a genuine catalyst for market stability or if it represents tactical manipulation, with many investors closely watching energy price volatility and its subsequent pressure on tech-heavy benchmarks.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant volatility driven by the intersection of high-profile legal developments, including a jury verdict regarding the company's past acquisition strategies, and broader macro-economic concerns surrounding geopolitical tensions and energy markets. Investors are actively debating the viability of long-term growth projects like the Terafab initiative versus immediate concerns over semiconductor supply, falling vehicle sales, and the company's valuation.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors digest the company's new "Super App" roadmap and aggressive plans to compete in the prediction markets sector. While retail sentiment remains divided over persistent price volatility and competitive threats, community discussion is currently focused on whether integration with major sports platforms and aggressive user acquisition can offset regulatory concerns and long-term margin pressures.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing intense volatility and aggressive liquidation as market participants grapple with a rapidly shifting macro environment defined by geopolitical tensions and surging bond yields. Community members are actively debating whether this sharp drawdown represents a terminal breakdown of golds safe-haven status or a tactical buying opportunity amid a broader liquidity crisis.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is surging as investors scramble to reprice natural gas exposure following reports of critical infrastructure damage to Qatar's LNG facilities, creating significant supply chain concerns. The community is actively discussing the stock's massive volume spike and potential for further volatility as energy sector participants debate the impact of the ongoing conflict on European supply security.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors react to the company's volatile price action amid high-stakes geopolitical tensions involving Iran. The community is sharply divided, with intense debate centering on the potential economic impact of recent executive foreign policy statements and ongoing concerns regarding broader market instability.

iShares Trust - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The Russell 2000 is under significant pressure as investors rotate into safe-haven assets and hedge against stagflation risks amid escalating Middle East tensions and rising energy costs. Community sentiment is deeply divided between traders capitalizing on the high volatility via aggressive options flow and those expressing concern over the structural impact of geopolitics on the broader economic cycle.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh the significant supply disruptions to global natural gas infrastructure against the company's aggressive expansion and capacity to leverage spot market pricing. The community remains highly focused on potential short squeeze setups and the long-term impact of regional geopolitical instability on LNG energy prices.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is surging as traders respond to heightened geopolitical tensions in the Middle East and spiking oil prices, which have triggered a sharp rotation into volatility-linked assets. The community is actively debating the sustainability of this price action, with many weighing the potential for further spikes against concerns over structural decay and market maker suppression of volatility products.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of "Reduce" by Brokerages

Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) have earned an average rating of "Reduce" from the five analysts that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has...

Canaccord Genuity Group Issues Pessimistic Forecast for Pliant Therapeutics (NASDAQ:PLRX) Stock Price

Canaccord Genuity Group lowered their price target on Pliant Therapeutics from $4.00 to $3.00 and set a "hold" rating for the company in a research note on Friday...

Pliant Therapeutics (NASDAQ:PLRX) Issues Quarterly Earnings Results

Pliant Therapeutics (NASDAQ:PLRX - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus...

Pliant Therapeutics Pivots to Oncology, Highlights Early PLN-101095 Responses at Oppenheimer Conference

Pliant Therapeutics (NASDAQ:PLRX) used its presentation at Oppenheimer's 36th Annual Healthcare Conference to outline its strategic transition toward oncology following the discontinuation of its...

Pliant Therapeutics (PLRX) Expected to Announce Quarterly Earnings on Monday

Pliant Therapeutics (NASDAQ:PLRX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 2. (View Earnings Report at...

Pliant Therapeutics (NASDAQ:PLRX) CEO Sells $114,400.00 in Stock

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) CEO Bernard Coulie sold 89,375 shares of the business's stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at...

Bernard Coulie Sells 89,375 Shares of Pliant Therapeutics (NASDAQ:PLRX) Stock

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) CEO Bernard Coulie sold 89,375 shares of the firm's stock in a transaction on Tuesday, January 20th. The stock was sold at an average price...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Reduce" by Analysts

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) has been assigned an average recommendation of "Reduce" from the fourteen ratings firms that are currently covering the stock, MarketBeat...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Short Interest Down 20.3% in December

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) was the target of a large decline in short interest during the month of December. As of December 15th, there was short interest totaling...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Reduce" by Brokerages

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) has earned a consensus rating of "Reduce" from the fourteen ratings firms that are currently covering the firm, MarketBeat reports. Two...

Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.

PLRX
Pliant Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PLRX News

PLRXPliant Therapeutics Inc